Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

RCUSRCUS
Showing 3 of 12 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in Arcus Biosciences, Inc.

BAKER BROS. ADVISORS LP holds 844,816 shares of RCUS (Arcus Biosciences, Inc.), worth $26M as of 2026-Q2. The position was increased (+103.3% shares). RCUS represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$26M

Current Shares

844,816

Total Value Change

+$19.6M

Total Shares Change

+574,816

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
844,816
+103.3%
$26M0.1%$30.83
55
2026-Q1
Increased
415,621
+53.9%
$9M0.1%$22.43
39
2025-Q4
New
270,000
-
$6.4M0.0%$23.23
38

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used